Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
US war in Iran has cost $29 billion so far, Pentagon says
At Temple of Heaven summit, Trump and Xi will seek a good harvest
Peace deal hopes fade after Trump rejects Iran proposal
Protests erupt after key college entrance test cancelled in India
UK's Starmer defies calls to quit, says he is getting on with governing
New Israeli law sets military tribunal for those linked to October 7 attack
Russia strikes Ukraine with drones as ceasefire ends
Dutch hospital quarantines 12 over breach of hantavirus protocol
